Affiliation:
1. V.V. Institute of Pharmaceutical Sciences, Gudlavalleru, India
Abstract
The emergence of the COVID-19 pandemic has brought to light a complex interplay between viral infections and pre-existing medical conditions. Among these, individuals with existing coronary artery disease (CAD) have been identified as a particularly vulnerable population. Amid the evolving landscape of healthcare, exploring the interconnection between coronary artery disease (CAD) and COVID-19 is of paramount significance. This work delves into the aggravated complications of CAD when coupled with COVID-19. It scrutinizes the multifaceted interplay, encompassing cardiovascular, immunological, and inflammatory facets. The chapter navigates through management challenges, treatment considerations, and preventive strategies while citing case studies. The chapter illuminates the symbiotic relationship, shedding light on research insights, future implications, and possible interventions. As CAD remains a global health burden, understanding its intersection with the pandemic aids in comprehensive patient care.
Reference17 articles.
1. American College of Cardiology. (2021). Management of Acute Coronary Syndrome Patients Presenting with COVID-19. https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2021/01/25/14/31/management-of-acute-coronary-syndrome-patients-presenting-with-covid-19
2. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: Mixed treatment comparison meta-analysis.;S.Bangalore;BMJ (Clinical Research Ed.),2020
3. ST-Segment Elevation in Patients with Covid-19 — A Case Series
4. Centers for Disease Control and Prevention. (2021). Vaccines for Children and Teens. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations
5. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era